GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PLx Pharma Inc (FRA:1D5A) » Definitions » Shiller PE Ratio

PLx Pharma (FRA:1D5A) Shiller PE Ratio : (As of May. 17, 2024)


View and export this data going back to 2014. Start your Free Trial

What is PLx Pharma Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


PLx Pharma Shiller PE Ratio Historical Data

The historical data trend for PLx Pharma's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PLx Pharma Shiller PE Ratio Chart

PLx Pharma Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PLx Pharma Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PLx Pharma's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, PLx Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PLx Pharma's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PLx Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PLx Pharma's Shiller PE Ratio falls into.



PLx Pharma Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

PLx Pharma's E10 for the quarter that ended in Sep. 2022 is calculated as:

For example, PLx Pharma's adjusted earnings per share data for the three months ended in Sep. 2022 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2022 (Change)*Current CPI (Sep. 2022)
=0/125.2265*125.2265
=0.000

Current CPI (Sep. 2022) = 125.2265.

PLx Pharma Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201212 9.167 96.871 11.850
201303 -0.556 98.209 -0.709
201306 -0.485 98.518 -0.616
201309 -1.257 98.790 -1.593
201312 -1.619 98.326 -2.062
201403 -2.545 99.695 -3.197
201406 -2.708 100.560 -3.372
201409 -2.794 100.428 -3.484
201412 -2.465 99.070 -3.116
201503 -3.622 99.621 -4.553
201506 -3.350 100.684 -4.167
201509 -3.493 100.392 -4.357
201512 -3.966 99.792 -4.977
201603 -4.023 100.470 -5.014
201606 -0.294 101.688 -0.362
201609 -0.223 101.861 -0.274
201612 -0.313 101.863 -0.385
201703 -0.309 102.862 -0.376
201706 -0.320 103.349 -0.388
201709 -0.369 104.136 -0.444
201712 -0.760 104.011 -0.915
201803 0.462 105.290 0.549
201806 -0.351 106.317 -0.413
201809 -0.334 106.507 -0.393
201812 0.299 105.998 0.353
201903 -2.398 107.251 -2.800
201906 -0.974 108.070 -1.129
201909 0.082 108.329 0.095
201912 -0.225 108.420 -0.260
202003 0.072 108.902 0.083
202006 -0.586 108.767 -0.675
202009 -0.340 109.815 -0.388
202012 -0.715 109.897 -0.815
202103 -0.613 111.754 -0.687
202106 -0.656 114.631 -0.717
202109 -0.680 115.734 -0.736
202112 -0.646 117.630 -0.688
202203 -0.354 121.301 -0.365
202206 -0.407 125.017 -0.408
202209 0.000 125.227 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PLx Pharma  (FRA:1D5A) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


PLx Pharma Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of PLx Pharma's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PLx Pharma (FRA:1D5A) Business Description

Traded in Other Exchanges
N/A
Address
8 The Green, Suite 11895, Dover, DE, USA, 19901
PLx Pharma Winddown Corp Formerly PLx Pharma Inc is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard drug delivery platform designed to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the GI tract. It believes this platform has the potential to improve the absorption of many drugs currently on the market or in development and to reduce the risk of stomach erosions and ulcers associated with drugs. VAZALORE is a novel formulation of aspirin clinically shown to provide fast, reliable and predictable platelet inhibition for patients with vascular disease and diabetic patients who may be candidates for aspirin therapy.

PLx Pharma (FRA:1D5A) Headlines

No Headlines